BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 1, 2020
View Archived Issues
City of Hope begins phase I study of 64Cu-DOTA-alendronate PET imaging of breast calcifications
Read More
Novartis opens phase II trial of CMK-389 for chronic pulmonary sarcoidosis
Read More
Field Trip Psychedelics successfully completes GLP synthesis of its preclinical candidate, FT-104
Read More
BCX-9930 shows clinical benefit as monotherapy in treatment-naive patients with PNH
Read More
Roche and Genentech present lipoprotein signal peptidase inhibitors
Read More
Mcl-1 inhibitors patented by Zeno Management
Read More
University of Texas, University of Arkansas discover GRB2 inhibitors
Read More
Translational Genomics Research Institute discloses CDK7 inhibitors
Read More
Propella Therapeutics presents new abiraterone prodrugs
Read More
Bacterial/viral combination is linked to postinfectious hydrocephalus
Read More
Creative Medical Technology reports preclinical data on ImmCelz in rheumatoid arthritis model
Read More
Positive topline data presented from ILLUMINATE-B phase III study of lumasiran
Read More
First patients dosed in phase IIa study of COVID-19 vaccine candidate, CVnCoV
Read More
MedinCell begins the first study of its COVID-19 prevention program
Read More
Myozenin-1 levels increase to ameliorate diabetic sarcopenia
Read More
Eisai initiates MOMENTUM 1 study of lorcaserin in Dravet syndrome
Read More
Allergan withdraws uterine fibroid drug Fibristal from Canadian market
Read More
Reduction in CNS recurrence for adjuvant osimertinib in NSCLC
Read More
Intellia presents preclinical data on CRISPR/Cas9 platform
Read More
Phase I/IIa extension data with arfolitixorin show 55% ORR in metastatic colorectal cancer
Read More
First-in-human data for camidanlumab tesirine in advanced solid tumors
Read More
ARCADE and ENDYMION results with soticlestat show seizure frequency reduction in rare epilepsies
Read More
Galapagos begins patient dosing with GLPG-3970 in psoriasis
Read More
Phase III study clearance in China for eftansomatropin in pediatric growth hormone deficiency
Read More
Enlivex reports data on use of Allocetra in COVID-19 patients in severe or critical condition
Read More
Codiak initiates phase I/II study of exoSTING for solid tumors
Read More
